VIRSIK PETER (Chief Operating Officer) sold 7.6% of their position (694.00 shares) of ESSA PHARMA INC. on the open market
Open‑market sale worth $4.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2024ACC: 0000950170-24-104661
Officer· Chief Operating Officer
Since Oct 2020
-694.00
Net shares
Net seller
$4.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
694.00 disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−694.00
Price / share
$6.00
Trade value
$4.16K
% of position
7.6%
9/9/2024
9.16K→8.47K
Total
Net shares
−694.00
Net value
-$4.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/9/2024 | S · Sale | −694.00 | $6.00 | $4.16K | 7.6% | 9.16K | 8.47K |
| Total | −694.00 | -$4.16K | ||||||
Derivative Transactions0
No derivative transactions reported